Search results
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 6 days agoThis was the first research project conducted to evaluate the immunity induced by the Pfizer-...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 1 day agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 15 hours agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 7 days agoWhat's Going On With Pfizer Stock On Thursday?
Scholz promises support for pharma sector in Germany as Merck invests
Reuters· 7 days ago, opens new tab, which is investing 1.5 billion euros ($1.61 billion) in Germany. The drugmaker...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 3 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Analysis | Whatever happened to Biden’s public option?
Washington Post· 6 days agoAs we ramp up for the 2024 election, I’ve wondered why talk of the public option has disappeared....
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle -...
Benzinga· 6 days agoCanadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV CVAC have settled...
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
Reuters· 6 days agoBiotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit...